Suven Pharma inks non-exclusive licencing pact with IICT, NIIST for 2-DG & Molnupiravir process tech, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The agreements for 2-DG and Molnupiravir involve a total fee of Rs 8 lakh plus taxes for grant of licences on non-exclusive basis., The agreements for 2-DG and Molnupiravir involve a total fee of Rs 8 lakh plus taxes for grant of licences on non-exclusive basis., , Read More